DENVER--(BUSINESS WIRE)--

MPEG LA announced today that Librassay, a landmark collaboration with the National Institutes of Health (NIH) and other leading healthcare innovators (listed below), is now providing one-stop worldwide access to diagnostic discoveries for personalized medicine.

Uncertainties surrounding access to patented technologies have imperiled healthcare advances, said Larry Horn, MPEG LA President and CEO. Just as MPEG LAs origination of patent pools provided a market-based solution for accessing consumer electronics, video and information technologies, now MPEG LAs Librassay introduces a similar solution to the healthcare market with the potential for profound cost savings and quality of life benefits. We applaud the pioneering foresight and efforts of the worlds leading research institutions demonstrating a commitment to their understanding that making world class medical technology widely available is as important as inventing it.

The NIHs policy is to disseminate its technologies as broadly as possible to promote commercialization and improve public health, stated Mark Rohrbaugh, Director of the NIH Office of Technology Transfer. This agreement promotes our policy by permitting MPEG LA and Librassay to pool patented technologies contributed by NIH with complementary technologies from other sources, and to grant non-exclusive, commercial licenses from the pool for in vitro diagnostics and personalized medicine.

Before Librassay, obtaining licenses to medical diagnostic inventions was an ordeal, added Kristin Neuman, Librassay Executive Director. Now Librassay offers one place where diagnostic developers and service providers can obtain assured and affordable access to patent rights, and patent holders have the opportunity for wider adoption of their technologies in combination with others, reasonable compensation for their research investments and the incentive to invest more.

Initial contributors to Librassay include

Starting with some 400 patents, Librassay makes worldwide medical diagnostic patent rights from the worlds leading research institutions available to everyone through a one-stop license. Librassay is expected to be of particular benefit in connection with emerging multiplexed diagnostic tests for disease and other health conditions, including whole genome sequencing, for which patent rights belonging to many different parties may be needed.

MPEG LA welcomes other patent holders to join Librassay. For information, please go to LicensorInfo-Librassay@mpegla.com.

To access the on-line Librassay store, or request a copy of the Librassay Patent Portfolio License, please go to http://www.librassay.com.

MPEG LA, LLC

More here:
MPEG LA’s Librassay® Removes Patent Barriers to Diagnostics for Personalized Medicine

Comments are closed.